EVALUATION AND VALIDATION OF THE PROGNOSTIC VALUE OF ANTI-MDA5 IGG SUBCLASSES IN DERMATOMYOSITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE

被引：0
|
作者：
Xu, Yue-Tong [1 ,2 ]
Zhang, Ya-Mei [3 ]
Yang, Hong-Xia [1 ]
Ye, Li-Fang [1 ,2 ]
Chen, Fang [1 ]
Lu, Xin [1 ]
Wang, Guo-Chun [1 ,2 ]
Peng, Qing-Lin [1 ,2 ]
机构：
[1] China Japan Friendship Hosp, Dept Rheumatol, Key Lab Myositis, Yinghua East Rd, Beijing 100029, Peoples R China
[2] Chinese Acad Med Sci, Peking Union Med Coll, Beijing 100730, Peoples R China
[3] Capital Med Univ, Beijing Friendship Hosp, Dept Nephrol, Yongan Rd, Beijing 100050, Peoples R China
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2023年 / 41卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-31
引用
收藏
页码：449 / 449
页数：1
相关论文
共 50 条
  • [1] Evaluation and validation of the prognostic value of anti-MDA5 IgG subclasses in dermatomyositis-associated interstitial lung disease
    Xu, Yue-Tong
    Zhang, Ya-Mei
    Yang, Hong-Xia
    Ye, Li-Fang
    Chen, Fang
    Lu, Xin
    Wang, Guo-Chun
    Peng, Qing-Lin
    RHEUMATOLOGY, 2022, 62 (01) : 397 - 406
  • [2] Clinical Features and Prognostic Factors for Dermatomyositis-Associated Interstitial Lung Diseases with Anti-MDA5 Antibody
    Fujisawa, T.
    Hozumi, H.
    Yasui, H.
    Suzuki, Y.
    Karayama, M.
    Furuhashi, K.
    Enomoto, N.
    Nakamura, Y.
    Inui, N.
    Suda, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [3] Assessment of anti-MDA5 antibody as a diagnostic biomarker in patients with dermatomyositis-associated interstitial lung disease or rapidly progressive interstitial lung disease
    Li, Liubing
    Wang, Qian
    Wen, Xiaoting
    Liu, Chenxi
    Wu, Chanyuan
    Yang, Funing
    Zeng, Xiaofeng
    Li, Yongzhe
    ONCOTARGET, 2017, 8 (44) : 76129 - 76140
  • [4] Progressive Interstitial Lung Disease Associated With Anti-MDA5 Positive Dermatomyositis
    Vahabzadeh, A.
    Ventimiglia, W. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [5] ANTI-MDA5 (+) CLINICALLY AMYOPATHIC DERMATOMYOSITIS-ASSOCIATED RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE: ROLE OF HEMOPERFUSION WITH POLYMYXIN
    Selva-O'callaghan, A.
    Vizcaino, C.
    Ruiz-Rodriguez, J. C.
    Trallero-Araguas, E.
    Ramos, N.
    Berastegui, C.
    Gil Vila, A.
    Martinez, M. A.
    Solanich, X.
    Ferrer, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1095 - 1095
  • [6] Rapidly Progressive Interstitial Lung Disease Associated with Anti-MDA5 Dermatomyositis
    Thomas, M.
    Deshpande, P.
    Tran, L.
    Sampath, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [7] PROGRESSIVE INTERSTITIAL LUNG DISEASE ASSOCIATED WITH ANTI-MDA5 POSITIVE DERMATOMYOSITIS
    Vahabzadeh, Arshia
    Ventimiglia, William A.
    CHEST, 2023, 164 (04) : 3217A - 3217A
  • [8] Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis
    Wanlong Wu
    Li Guo
    Yakai Fu
    Kaiwen Wang
    Danting Zhang
    Wenwen Xu
    Zhiwei Chen
    Shuang Ye
    Clinical Reviews in Allergy & Immunology, 2021, 60 : 293 - 304
  • [9] Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis
    Wu, Wanlong
    Guo, Li
    Fu, Yakai
    Wang, Kaiwen
    Zhang, Danting
    Xu, Wenwen
    Chen, Zhiwei
    Ye, Shuang
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2021, 60 (02) : 293 - 304
  • [10] Rituximab in the treatment of anti-MDA5 dermatomyositis-associated interstitial lung disease: a case-based literature review
    Nascimento, J.
    Tenazinha, C.
    Campanilho-Marques, R.
    Cordeiro, I
    Salgado, S.
    ARP RHEUMATOLOGY, 2022, 1 (02): : 168 - 173
12345